Transgenic Mice Overexpressing Nuclear SREBP-1c in Pancreatic β-Cells
- Akimitsu Takahashi1,
- Kaori Motomura1,
- Toyonori Kato1,
- Tomohiro Yoshikawa1,
- Yoshimi Nakagawa12,
- Naoya Yahagi2,
- Hirohito Sone1,
- Hiroaki Suzuki1,
- Hideo Toyoshima1,
- Nobuhiro Yamada1 and
- Hitoshi Shimano12
- 1Department of Internal Medicine (Metabolism and Endocrinology), Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tennodai, Tsukuba, Ibaraki, Japan
- 2Center for Tsukuba Advanced Research Alliance, University of Tsukuba, Tennodai, Tsukuba, Ibaraki, Japan
- Address correspondence and reprint requests to Hitoshi Shimano, MD, PhD, Department of Internal Medicine, Institute of Clinical Medicine and Center for Tsukuba Advanced Research Alliance, University of Tsukuba, Tennodai, Tsukuba, Ibaraki 305-8575, Japan. E-mail: shimano-tky{at}umin.ac.jp
Abstract
Influx of excess fatty acids and the resultant accumulation of intracellular triglycerides are linked to impaired insulin secretion and action in the pathogenesis of type 2 diabetes. Sterol regulatory element-binding protein (SREBP)-1c is a transcription factor that controls cellular synthesis of fatty acids and triglycerides. SREBP-1c is highly expressed in high-energy and insulin-resistant states. To investigate effects of this synthetic lipid regulator on insulin secretion, we generated transgenic mice overexpressing nuclear SREBP-1c under the insulin promoter. β-Cell-specific expression of SREBP-1c caused reduction in islet mass and impaired glucose-stimulated insulin secretion and was associated with accumulation of triglycerides, suppression of pancreas duodenal homeobox-1, and upregulation of uncoupling protein 2 gene expression. The mice presented with impaired glucose tolerance that was exacerbated by a high-energy diet. Taken together with enhanced insulin secretion from SREBP-1-null islets, these data suggest that SREBP-1c and endogenous lipogenesis could be involved in β-cell dysfunction and diabetes.
- CPT, carnitine palmitoyltransferase
- FAS, fatty acid synthase
- FFA, free fatty acid
- GSIS, glucose-stimulated insulin secretion
- HFHS, high fat/high sucrose
- IGT, impaired glucose tolerance
- IRS, insulin receptor substrate
- KRBH, Krebs-Ringer bicarbonate buffer with 10 mmol/l HEPES
- Nkx6.1, NK6 transcription factor related, locus 1
- Pdx, pancreas duodenal homeobox
- RIP, rat insulin I promoter
- SCD, stealyl CoA desaturase
- SREBP, sterol regulatory element-binding protein
- UCP, uncoupling protein
Footnotes
-
A.T., K.M., and T.K. contributed equally to this work.
-
- Accepted November 11, 2004.
- Received June 3, 2004.
- DIABETES











